Viyash Scientific Ltd

Viyash Scientific Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Viyash Scientific Ltd

₹ 248 -0.78%
03 Jun - close price
sequent.in BSE: 512529 NSE: VIYASH
About

Sequent Scientific is India's leading animal health company, with presence in 5+ continents across 100 countries. Sequent Scientific Limited provides a wide-ranging portfolio of animal health products, including Finished Dose Formulations, APIs, as well as analytical services to the pharmaceutical and life sciences industries.

Key Points

Business segments
The company has 2 business segments: Formulation and API. [1]

Website BSE NSE
  • Market Cap ₹ 10,830 Cr.
  • Current Price ₹ 248
  • High / Low ₹ 277 / 166
  • Stock P/E 54.2
  • Book Value ₹ 66.6
  • Dividend Yield 0.00 %
  • ROCE 19.0 %
  • ROE 11.0 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company is expected to give good quarter

Cons

  • Stock is trading at 3.72 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 6.14% over last 3 years.
  • Working capital days have increased from 70.3 days to 111 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE Healthcare Nifty Microcap 250 Nifty Total Market BSE 1000 Nifty Smallcap 500

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
367 333 346 329 361 390 369 774 402 441 850 858 920
370 341 331 307 329 348 330 674 355 389 677 683 736
Operating Profit -3 -8 15 22 32 42 39 100 46 52 173 176 184
OPM % -1% -2% 4% 7% 9% 11% 11% 13% 12% 12% 20% 20% 20%
-60 -23 10 7 -1 3 0 4 1 3 6 -27 16
Interest 11 10 13 13 12 16 14 21 15 14 18 17 15
Depreciation 15 14 15 15 16 16 17 58 16 15 59 59 60
Profit before tax -89 -56 -3 1 3 12 8 24 16 26 102 73 125
Tax % 4% -38% 123% -617% 52% 24% 20% -71% 36% 31% 29% 34% 47%
-92 -35 -7 11 1 9 6 42 10 18 73 49 66
EPS in Rs -3.75 -1.40 -0.34 0.33 -0.04 0.26 0.10 1.78 0.37 0.57 2.18 0.88 1.19
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
443 606 684 848 1,039 1,179 1,362 1,413 1,421 1,370 1,551 3,420
425 550 641 765 914 1,009 1,150 1,303 1,409 1,308 1,390 2,768
Operating Profit 18 56 43 83 125 170 212 109 12 61 162 653
OPM % 4% 9% 6% 10% 12% 14% 16% 8% 1% 4% 10% 19%
48 14 9 436 9 10 -0 11 -58 -6 10 -1
Interest 43 38 28 33 33 36 24 16 36 48 61 69
Depreciation 32 46 40 41 42 51 51 52 56 62 66 234
Profit before tax -8 -14 -17 444 59 94 137 53 -138 -55 44 349
Tax % 40% 19% -3% 3% 3% 13% 24% 15% -11% -46% 27% 36%
-12 -16 -16 431 57 82 104 45 -122 -30 32 225
EPS in Rs -0.70 -0.78 -0.57 17.30 1.97 2.81 3.84 1.65 -4.86 -1.44 0.87 4.06
Dividend Payout % 0% 0% 0% 1% 10% 0% 13% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 19%
5 Years: 20%
3 Years: 34%
TTM: 120%
Compounded Profit Growth
10 Years: 28%
5 Years: 15%
3 Years: 73%
TTM: 816%
Stock Price CAGR
10 Years: 7%
5 Years: -1%
3 Years: 50%
1 Year: 29%
Return on Equity
10 Years: 9%
5 Years: 4%
3 Years: 6%
Last Year: 11%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 30 48 49 49 49 50 50 50 50 50 50 87
Reserves 61 898 928 599 657 637 678 642 649 607 654 2,824
473 312 416 305 325 343 277 365 444 488 481 490
343 265 503 380 346 424 381 378 374 389 412 1,228
Total Liabilities 908 1,523 1,896 1,332 1,378 1,454 1,386 1,435 1,517 1,534 1,598 4,628
474 586 684 476 498 577 536 564 605 592 586 2,105
CWIP 39 24 33 18 23 13 31 12 55 16 16 69
Investments 59 428 428 239 180 171 83 38 0 4 0 0
336 485 751 599 677 693 737 821 856 922 996 2,455
Total Assets 908 1,523 1,896 1,332 1,378 1,454 1,386 1,435 1,517 1,534 1,598 4,628

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
-24 -0 -7 45 116 115 115 31 17 31 83 323
-157 -310 -116 7 -68 -72 10 -94 -65 -6 -25 -84
179 309 147 -57 -20 -43 -139 67 32 -1 -61 -123
Net Cash Flow -1 -2 24 -5 28 0 -14 4 -16 23 -2 115
Free Cash Flow -137 -63 -82 0 92 75 70 -1 -58 19 54 225
CFO/OP -143% -3% 5% 65% 92% 75% 75% 52% 263% 73% 69% 59%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 95 116 136 111 98 99 93 85 88 89 85 112
Inventory Days 153 164 165 125 134 132 139 160 152 166 173 188
Days Payable 147 175 208 127 141 133 119 119 107 121 115 140
Cash Conversion Cycle 101 105 93 110 92 98 112 126 132 135 143 160
Working Capital Days -111 65 -25 20 33 29 51 54 46 30 70 111
ROCE % 8% 2% 1% 40% 9% 12% 16% 6% -3% 0% 8% 19%

Insights

In beta
Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2025
Number of Commercial APIs
Number

Log in to view insights

Please log in to see hidden values.

Login
Global Employee Headcount
Number
Global Presence (Countries Reached)
Number
Number of Finished Dosage Forms (FDFs)
Number
Number of Manufacturing Facilities
Number
R&D Expenditure
INR Million
R&D Expenditure (Percentage of Turnover)
% ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
52.79% 52.79% 52.79% 52.79% 52.78% 52.76% 52.61% 52.61% 52.61% 52.33% 61.41% 61.31%
6.27% 6.03% 6.12% 6.16% 5.69% 6.45% 6.10% 6.05% 6.15% 5.90% 3.16% 2.94%
2.92% 3.23% 7.23% 7.59% 8.06% 9.99% 12.01% 12.82% 12.98% 12.91% 7.36% 7.98%
37.64% 37.57% 33.69% 33.29% 33.30% 30.63% 29.12% 28.36% 28.10% 28.69% 27.97% 27.67%
0.39% 0.39% 0.17% 0.17% 0.17% 0.17% 0.16% 0.16% 0.16% 0.16% 0.09% 0.09%
No. of Shareholders 1,87,4741,84,5211,72,8531,66,5931,63,6931,54,6031,62,5741,58,1521,47,3201,44,0851,34,1941,27,446

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls